PATENT CLAIM ANALYSIS

Application Number: 16214973
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-10
Patent Classification: ["514", "310000"]

Abstract:
Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.

Claim (Index 16):
The method of  claim 15 , wherein the at least a second rho kinase inhibitor is BA-1042, BA-1043, BA-1044, BA-1050, BA-1051, C3, KD025, Rhopressa, Roclatan, AR-13533, Fasudil, HA-1077, Radicut, Azandoile 1, BF66851, BF66852, BF66853, Y27632 Y33075, Y27632 dihydrochloride, Y 33075 dihydrochloride, K115 free base (isoquinolinesulfonamide), SAR407899 hydrochloride, SR 3677, LX7101, RXI-1447, SAR407899, Thiazovivin, Chroman 1, Fasudil hydrochloride, GSK429286A, H-115 dihydrochloride, Hydroxyfasudil hydrochloride, GSK269962, H-1152, Hydroxyfasudil, K-115 (Ripasudil), a rho kinase inhibitor set forth in  FIG. 10A  or  FIG. 10B , or a mixture thereof.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 98.0
- Lexical Diversity: 1.22727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15590815', '15006314', '15591039', '15988736', '15173079']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7841179201573332
- 35 USC 102 Novelty (BERT): 0.6961606620698697
- Combined Prediction Score: 0.7753221943485868
- Mean Citation Score: 535.738126
- Max Citation Score: 893.6043
- Similarity Product: 677.9357294785023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test